Among biotech and emerging pharmaceutical companies, Gilead Sciences (NASDAQ: GILD) and Onyx Pharmaceuticals (NASDAQ: ONXX ... Idec stock has outperformed that of larger competitor Pfizer (NYSE: PFE), as well as the broader …
The rare bone marrow cancer myelofibrosis is hardly a household name ... Incyte (INCY), YM Biosciences (YMI), Onyx Pharmaceuticals (ONXX) are among the drug companies presenting data on mid-stage human studies at the American …
Welcome to the Stock ... Amgen topped the Street view in terms of earnings projections but is slightly below the consensus sales forecast. I’m not overly concerned about this. Now that Amgen has acquired cancer drug specialist …
Highlighted stocks include: Myriad Genetics (Nasdaq: MYGN), Onyx Pharmaceuticals Inc. (Nasdaq: ONXX), AMAG …
Half of the 28 analysts surveyed by Thomson/First Call recommend buying shares. They believe the stock has some room to run as their mean price target is a more than 10 percent higher than the current share price. That target would be a …
Apple (AAPL) traded inverse to the market again on Friday, as the stock closed in the green with 0.70% of gains ... for a potential move back to highs at $115. Onyx Pharma (ONXX) is up big this morning and could give a lift to this group.
Upon breaching this level, it may go down to $94.54 level. Onyx traded 942,150 shares during yesterday’s session, and the stock oscillated in the range of $97.82 and $101.43. ONXX has appreciated 123.04 percent in the past 52 weeks. The …
Onyx Pharmaceuticals (ONXX): Shares get upgraded to Buy from Hold at Jefferies. Schlumberger (SLB): Argus upgrades the oil services outfit to Buy from Hold on account of its impressive execution. Valero Energy (VLO): The stock is now …
The stock pulled back at the end of the day and finished up only ... Shares of Amgen (AMGN) rose sharply after it agreed to buy Onyx Pharmaceuticals (ONXX) for $10.4 billion, in a deal that will give Amgen access to a wide range of cancer …
In evaluating U.S. public-to-public takeovers since the beginning of July 2013, the stock of the acquiring companies have gained ... On August 25, announced a deal to acquire Onyx Pharmaceuticals (NASDAQ: ONXX) for $10.4 billion. …